{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T04:41:48Z","timestamp":1759898508781,"version":"build-2065373602"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>X-linked lymphoproliferative syndrome type 1 (XLP-1) is a life-threatening X-linked recessive immunodeficiency classically characterized by susceptibility to Epstein\u2013Barr virus (EBV), hypogammaglobulinemia, and lymphoma. While neurological involvement can occur, it is exceptionally rare as the initial and predominant manifestation. This case report details a novel presentation of XLP-1 in a 4-year-old boy who presented with acute, initial neurological symptoms (sudden fever, headache, and vomiting) in the absence of typical immune dysregulation features. Whole-exome sequencing (WES) identified a hemizygous variant in the SH2D1A gene (c.1A&amp;gt;G, p. Met1Val), predicted as damaging\/disease-causing by MutationTaster (probability = 0.993) and PolyPhen-2 (probability = 0.992). Meanwhile, according to the American College of Medical Genetics and Genomics (ACMG) guidelines for variant interpretation, this variant met four evidence criteria (PVS1_Moderate+ +PM2_Moderate+PP3+PP5) and was classified as pathogenic. Structural analysis leveraging the AlphaFold protein structure database demonstrated that this variant disrupts the Kozak consensus sequence and splice site, critically impairing start codon recognition and translation initiation, thereby explaining the loss of functional SLAM-associated protein (SAP) protein expression. This case, along with a focused review of the literature, underscores that XLP-1 rarely presents primarily with neurological symptoms, broadening the clinical phenotype spectrum and emphasizing the need for early genetic evaluation in children with unexplained acute neurological presentations, even in the absence of overt immunodeficiency signs. This finding provides crucial clinical data for a more comprehensive understanding of XLP-1.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1677958","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T04:17:26Z","timestamp":1759897046000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["X-linked lymphoproliferative disease with initial onset of neurological symptoms: a case and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Lijun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)92004-8","article-title":"X-linked recessive progressive combined variable immunodeficiency (Duncan\u2019s disease)","volume":"1","author":"Purtilo","year":"1975","journal-title":"Lancet (London England)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199510000-00001","article-title":"X-linked lymphoproliferative disease: twenty-five years after the discovery","volume":"38","author":"Seemayer","year":"1995","journal-title":"Pediatr Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.clim.2018.12.016","article-title":"Management of XLP-1 and ITK deficiency: The challenges posed by PID with an unpredictable spectrum of disease manifestations","volume":"198","author":"Shadur","year":"2019","journal-title":"Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1023\/b:Joci.0000040922.26286.36","article-title":"Persistent hypogammaglobulinemia following mononucleosis in boys is highly suggestive of X-linked lymphoproliferative disease\u2013report of three cases","volume":"24","author":"H\u00fcgle","year":"2004","journal-title":"J Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/10428190290026240","article-title":"A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses","volume":"43","author":"Sumegi","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2008.02128.x","article-title":"Follicular lymphoma in a X-linked lymphoproliferative syndrome carrier female","volume":"68","author":"Woon","year":"2008","journal-title":"Scand J Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e30951","DOI":"10.1097\/MD.0000000000030951","article-title":"Potential pathogenic mechanism of type 1 X-linked lymphoproliferative syndrome caused by a mutation of SH2D1A gene in an infant: A case report","volume":"101","author":"Wang","year":"2022","journal-title":"Med (Baltimore)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0144472","DOI":"10.1371\/journal.pone.0144472","article-title":"Acetyl-phosphate is not a global regulatory bridge between virulence and central metabolism in borrelia burgdorferi","volume":"10","author":"Richards","year":"2015","journal-title":"PloS One"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001585","article-title":"A novel missense mutation affecting the N-terminal domain of SAP protein in X-linked lymphoproliferative disease","volume":"41","author":"Furlong","year":"2019","journal-title":"J Pediatr Hematol\/Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/2042-4280-3-1","article-title":"Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2","volume":"3","author":"Yang","year":"2012","journal-title":"Herpesviridae"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00666","article-title":"X-linked lymphoproliferative disease type 1: A clinical and molecular perspective","volume":"9","author":"Panchal","year":"2018","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.747738","article-title":"Case report: meningoencephalitis with thrombotic occlusive vasculopathy in a young EBV-na\u00efve boy is associated with a novel SH2D1A mutation","volume":"12","author":"Steininger","year":"2021","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-006-0290-1","article-title":"Simultaneous manifestation of fulminant infectious mononucleosis with haemophagocytic syndrome and B-cell lymphoma in X-linked lymphoproliferative disease","volume":"166","author":"H\u00fcgle","year":"2007","journal-title":"Eur J Pediatr"},{"key":"B14","article-title":"Diffuse CNS vasculopathy with chronic Epstein-Barr virus infection in X-linked lymphoproliferative disease","volume":"27","author":"Weeks","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112140-20200710-00715","article-title":"Cerebral vasculitis in X-linked lymphoproliferative disease in a Chinese patient","volume":"59","author":"Liu","year":"2021","journal-title":"Chin J Pediatr"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002154","article-title":"Fatal central nervous system lymphocytic vasculitis after treatment for burkitt lymphoma in a patient with a SH2D1A mutation","volume":"38","author":"Neves","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-015-0194-9","article-title":"Cerebral vasculitis in X-linked lymphoproliferative disease cured by matched unrelated cord blood transplant","volume":"35","author":"Gray","year":"2015","journal-title":"J Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.5732\/cjc.012.10238","article-title":"Lymphoma and cerebral vasculitis in association with X-linked lymphoproliferative disease","volume":"32","author":"Zhu","year":"2013","journal-title":"Chin J Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000265597.56202.6c","article-title":"Limbic encephalitis as presentation of a SAP deficiency","volume":"69","author":"Verhelst","year":"2007","journal-title":"Neurology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"95\u2013100","DOI":"10.1182\/blood.V97.1.95","article-title":"Lymphocytic vasculitis in X-linked lymphoproliferative disease","volume":"97","author":"Dutz","year":"2001","journal-title":"Blood"},{"key":"B21","article-title":"Cutaneous and neurologic vasculitis disclosing EBV-selective immunodeficiency","volume":"123","author":"Grosieux","year":"1996","journal-title":"Annales Dermatol Et Venereol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X241275445","article-title":"Cerebral salt wasting syndrome in a child with central diabetes insipidus following surgery for recurrent craniopharyngioma: A case report","volume":"12","author":"Vir\u00fa-Loza","year":"2024","journal-title":"SAGE Open Med Case Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e2020022848","DOI":"10.1542\/peds.2020-022848","article-title":"Vasopressin-dependent disorders: what is new in children","volume":"147","author":"Driano","year":"2021","journal-title":"Pediatrics"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1381472","article-title":"Case report: Non-EBV associated cerebral vasculitis and cerebral hemorrhage in X-linked lymphoproliferative disease","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.jaci.2022.06.021","article-title":"Allosteric inhibition of SHP2 rescues functional T-cell abnormalities in SAP deficiency","volume":"150","author":"Panchal","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2965","article-title":"Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy","volume":"105","author":"Milone","year":"2005","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1677958\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T04:17:27Z","timestamp":1759897047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1677958\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":26,"alternative-id":["10.3389\/fimmu.2025.1677958"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1677958","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"article-number":"1677958"}}